Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
CLEO Diagnostics Ltd ( (AU:COV) ) just unveiled an announcement.
Cleo Diagnostics Ltd has announced its 2025 Annual General Meeting, scheduled for 24 November 2025, at RSM Australia Pty Ltd in Melbourne. The company will provide the Notice of Meeting electronically, encouraging shareholders to vote via directed proxy by 22 November 2025, reflecting a shift towards digital communication and engagement with stakeholders.
More about CLEO Diagnostics Ltd
Cleo Diagnostics Ltd operates in the medical diagnostics industry, focusing on the development and provision of diagnostic solutions. The company is based in Melbourne, Australia, and is listed on the Australian Securities Exchange under the ticker ASX:COV.
Average Trading Volume: 129,783
Technical Sentiment Signal: Strong Buy
Find detailed analytics on COV stock on TipRanks’ Stock Analysis page.